Lv2
160 积分 2025-04-27 加入
Two-Stage Plans Compared with Fixed-Sample-Size and Wald SPRT Plans
8天前
已完结
Individual patient data analysis to assess modifications to the RECIST criteria
9天前
已完结
Accelerated Titration Designs for Phase I Clinical Trials in Oncology
10天前
已完结
Optimal two-stage designs for phase II clinical trials
13天前
已完结
Overcoming Secondary Mutations of Type II Kinase Inhibitors
17天前
已完结
Discovery and optimization of selective RET inhibitors via scaffold hopping
1个月前
已完结
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
1个月前
已完结
Thirty Years of Progress Thanks to the RET Oncogene
2个月前
已完结
Evolving Epidemiology of Increasing Trauma Deaths in the UNITED STATES (2000-2020)
2个月前
已完结
CEP-32496: A Novel Orally Active BRAFV600E Inhibitor with Selective Cellular and In Vivo Antitumor Activity
2个月前
已完结
皖公网安备34019202002308
